All data are based on the daily closing price as of July 11, 2025
h

Hanmi Science Co.

008930.KO
34.16 USD
-0.44
-1.27%

Overview

Last close
34.16 usd
Market cap
2.31B usd
52 week high
37.77 usd
52 week low
17.04 usd
Target price
23.48 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.4925
Price/Book Value
3.7415
Enterprise Value
2.40B usd
EV/Revenue
2.5695
EV/EBITDA
43.8584

Key financials

Revenue TTM
934.82M usd
Gross Profit TTM
194.48M usd
EBITDA TTM
27.09M usd
Earnings per Share
N/A usd
Dividend
0.22 usd
Total assets
924.86M usd
Net debt
N/A usd

About

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
  • Symbol
    008930.KO
  • Exchange
    KO
  • Isin
    KR7008930000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Distribution
  • CEO
    Mr. Lim Chong-Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.hanmiscience.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top